Royal Bank of Canada’s OncoSec Medical Incorporated ONCS Stock Holding History

Royal Bank of Canada’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-45	Closed	-$3K	–	8196
2021 Q2	$3K	Sell	45 -28	-38%	-$2.54K	﹤0.01%	7223
2021 Q1	$8K	Buy	+73	New	+$9.99K	﹤0.01%	6921
2019 Q3	–	Sell	-1	Closed	–	–	7478
2019 Q2	$0	Buy	+1	New	+$96	﹤0.01%	7444
2018 Q4	–	Sell	-1	Closed	–	–	7440
2018 Q3	$0	Buy	+1	New	+$307	﹤0.01%	7156
2018 Q2	–	Hold	0	–	–	–	6959
2018 Q1	–	Hold	0	–	–	–	7095
2017 Q4	–	Hold	0	–	–	–	7165
2017 Q3	–	Hold	0	–	–	–	7178
2016 Q3	–	Hold	0	–	–	–	6696
2016 Q2	–	Hold	0	–	–	–	6647

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada's ONCS Position: Q3 2021 in Review

Royal Bank of Canada sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 45 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in ONCS in Q3 2018 and held it in 4 quarters. The position peaked at $8K in Q1 2021. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

Royal Bank of Canada reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
Royal Bank of Canada sold 45 OncoSec Medical Incorporated shares in Q3 2021, an estimated $3K.
Royal Bank of Canada first reported a position in OncoSec Medical Incorporated in Q3 2018 and held it in 4 quarters.
Royal Bank of Canada's OncoSec Medical Incorporated position peaked at $8K in Q1 2021.
31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.